KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy

BACKGROUND: This study was carried out to evaluate the prognostic value of KIBRA in breast cancer. METHODS: This retrospective study included breast cancer patients who sought the services of the immunohistochemistry laboratory of our unit from 2006 to 2015. Tissue microarrays were constructed and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mudduwa, Lakmini, Peiris, Harshini, Gunasekara, Shania, Abeysiriwardhana, Deepthika, Liyanage, Nimsha, Rayala, Suresh K., Liyanage, Thusharie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968668/
https://www.ncbi.nlm.nih.gov/pubmed/29793439
http://dx.doi.org/10.1186/s12885-018-4491-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968668/
https://www.ncbi.nlm.nih.gov/pubmed/29793439
http://dx.doi.org/10.1186/s12885-018-4491-6

Ejemplares similares